Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VITAL-AMD
NCT01782352Phase 3Unknown
- Sponsor
- Brigham and Women's Hospital
- Start
- Jul 2010
- Primary completion
- Dec 2019
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of omega-3-acid triglycerides, vitamin d in age-related macular degeneration (AMD), sponsored by Brigham and Women's Hospital. Status: unknown.
02
Drugs
omega-3-acid triglyceridesvitamin d
03
Conditions
age-related macular degeneration (AMD)
Beyond the preview
Go deeper on NCT01782352.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01782352.